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Abstract
 
Cadherins are integral membrane proteins expressed in tissue-restricted patterns that mediate
homophilic intercellular adhesion. During development, they orchestrate tissue morphogenesis
and, in the adult, they determine tissue integrity and architecture. The synovial lining is a con-
densation of fibroblast-like synoviocytes (FLS) and macrophages one to three cells thick. These
cells are embedded within the extracellular matrix, but the structure is neither an epithelium
nor an endothelium. Previously, the basis for organization of the synovium into a tissue was
unknown. Here, we cloned cadherin-11 from human rheumatoid arthritis (RA)-derived FLS.
We developed L cell transfectants expressing cadherin-11, cadherin-11 fusion proteins, and
anti–cadherin-11 mAb. Cadherin-11 was found to be expressed mainly in the synovial lining
by immunohistologic staining of human synovium. FLS adhered to cadherin-11–Fc, and trans-
fection of cadherin-11 conferred the formation of tissue-like sheets and lining-like structures
upon fibroblasts in vitro. These findings support a key role for cadherin-11 in the specific adhe-
sion of FLS and in synovial tissue organization and behavior in health and RA.
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Introduction
 
During development, the differential adhesive properties of
various cell populations facilitate the cell rearrangement re-
quired for tissue morphogenesis. This cell sorting is directed
in part by cadherins such as E-cadherin in epithelia and
N-cadherin in the nervous system. Postnatally, cadherins play
a major role in maintaining tissue integrity and architecture
(1, 2). Cadherins are transmembrane glycoproteins expressed
in restricted patterns that mediate homophilic adhesion be-
tween cells. In many tissues, adherens junctions are formed
by cadherins linked through intracellular catenins to the actin
cytoskeleton. These multiprotein complexes can activate
intracellular signaling pathways, influence cytoskeletal or-
ganization, and orchestrate multicellular arrangements (1,
2). These properties of cadherins are likely to contribute to
their role in tumor progression (2). Indeed, changes in cad-
herin expression have been associated with cell transforma-
tion and tumor metastasis (3–5).
The physiological role of the synovium is to balance car-
tilage remodeling and provide lubricant and nourishment
for the synovial fluid that bathes the avascular cartilage surfaces
of diarthrodial joints (6). The synovial membrane lining is
composed of two major cell types: type A, macrophage-
like synoviocyte, and type B, fibroblast-like synoviocyte
(FLS). These synoviocytes form cell to cell contacts as well
as attachments to an ordered extracellular matrix (ECM).
However, the lining lacks a classical basement membrane,
and the cellular contacts lack tight junctions and desmo-
somes (6, 7). Therefore, the lining does not possess the ar-
chitecture typical of epithelium or endothelium.
The synovium displays marked changes in rheumatoid
arthritis (RA) where the lining undergoes striking hyper-
plasia and the underlying loose connective tissue becomes
massively infiltrated with leukocytes. These changes are associ-
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ated with activation and condensation of the mesenchymal
synovial cells that produce large amounts of matrix-degrad-
ing metalloproteinases, inflammatory cytokines, and lipid
mediators of inflammation. This mass of cells extends and
attaches onto cartilage and becomes locally invasive, dam-
aging cartilage and eroding adjacent bone, resulting in per-
manent joint destruction.
Surprisingly, despite the central role of the synovial
membrane in diarthrodial joint physiology in health and in
inflammatory arthritis, little is known about the molecular
basis for the organization of this tissue (6, 7). We hypothe-
sized that cadherins might mediate homophilic adhesion
between synoviocytes and explain their organization into a
tissue. Here, we describe the identification and cloning of a
cadherin expressed in the lining of normal synovium, syn-
ovium in osteoarthritis, and the hyperplastic rheumatoid
synovium. This cadherin mediates adhesion of FLS and
confers features of synovial tissue formation upon fibro-
blasts in vitro.
 
Materials and Methods
 
Isolation and Culture of FLS.
 
Synovial tissues from RA pa-
tients (American College of Rheumatology criteria; reference 8)
were discarded tissue from synovectomy or joint replacement pro-
cedures, obtained with approval of the Brigham and Women’s
Hospital Institutional Review Board. Synoviocyte cell suspensions
were prepared from synovial tissues by mincing; treatment with 1
mg/ml collagenase (type 1; Worthington Biochemicals), 0.15 mg/
ml DNase I (Sigma-Aldrich), and 2 mM CaCl
 
2
 
 in HBS (20 mM
Hepes, 137 mM NaCl, and 3 mM KCl, pH 7.4); and rocking at
37
 
 
 
C for 1 h. The cell suspension was passed through a 40-mesh
sieve and cultured in DMEM, 10% FBS (Hyclone), 2 mM 
 
l
 
-glu-
tamine, 1 mM sodium pyruvate, 100 U/ml penicillin, 100 
 
 
 
g/ml
streptomycin sulfate, and 50 
 
 
 
M 2-mercaptoethanol at 37
 
 
 
C, 10%
CO
 
2
 
. After the third passage, cells appeared fibroblast-like and
were negative with anti-CD68 mAb, suggesting they were com-
posed mainly of FLS as described previously (9).
 
Northern Blots.
 
Messenger RNA was isolated as described
previously (10) from FLS after five passages, 16E6.A5 epithelial
cells, and Jurkat T leukemia cells. 5 
 
 
 
g per sample were subjected
to electrophoresis through 1.5% agarose/6% formaldehyde gels
and transferred onto a Hybond nylon membrane (Amersham
Biosciences). This membrane was probed serially with a 
 
32
 
P ran-
dom prime–labeled 385-bp fragment of candidate synovial cad-
herin followed by control GAPDH cDNA (CLONTECH Labo-
ratories, Inc.) at 43
 
 
 
C for 16 h. The membrane was washed at a
final stringency of 0.1 
 
 
 
 SSC with 2% (wt/vol) SDS at 56
 
 
 
C and
autoradiographed on Kodak MS film at 
 
 
 
70
 
 
 
C.
 
Adhesion Assays.
 
Cells were labeled with 15 
 
 
 
g of calcein-
AM (Molecular Probes) during release from culture flasks using
0.02% trypsin, 2 mM CaCl
 
2
 
 in HBS for 5 min at 37
 
 
 
C to mini-
mize cadherin proteolysis. After adding two volumes of 0.04%
soy bean trypsin inhibitor in HBS, they were washed twice and
resuspended in HBS, 0.1% BSA, 50 mM glucose, and 1 mM
CaCl
 
2
 
. Cells were allowed to settle for 10 min at 4
 
 
 
C onto cad-
herin–Fc-coated microtiter plates and, after incubation at 37
 
 
 
C
for 40 min, the percentage of adherent cells was determined as
described previously (11).
 
Immunohistochemical Analysis.
 
Synovial samples were snap-
frozen in OCT compound (Sakura Finetek, Inc.). 5-
 
 
 
m sections
were fixed in acetone at room temperature for 10 min, air dried,
and stained with the avidin–biotin complex method (12). The
sections were incubated with biotinylated antibodies or unconju-
gated antibodies followed by biotinylated horse anti–mouse
Ig (Vector Laboratories). Endogenous peroxidase activity was
blocked with 0.3% hydrogen peroxide in PBS. Endogenous bi-
otin was blocked by sequential incubations with avidin (Vector
Laboratories) and biotin (Sigma-Aldrich). The sections were de-
veloped with 3-amino-9-ethylcarbazole (Sigma-Aldrich), post-
fixed with in 2% paraformaldehyde, and counterstained with he-
matoxylin (Fisher Scientific).
 
Immunofluorescence and Flow Cytometry.
 
For confocal immu-
nofluorescence microscopy, cells were fixed in 2% paraformalde-
hyde in PBS for 15 min; permeabilized in 0.2% (wt/vol) saponin
in 60-mM pipes, 25 mM Hepes, 10 mM EGTA, and 2 mM
MgCl, pH 6.9, for 30 min; blocked; and incubated with primary
antibodies for 1 h at room temperature followed by Cy3-conju-
gated secondary antibody (Jackson ImmunoResearch Laborato-
ries) and Alexa 488–conjugated phalloidin (Molecular Probes) for
1 h at room temperature.
For flow cytometry, cultured cells were released essentially as
described for adhesion assays and stained with primary antibodies
in HBS, 1 mM CaCl
 
2
 
, 2% FBS for 1 h at 4
 
 
 
C followed by FITC-
conjugated secondary antibody for 1 h at 4
 
 
 
C, and analyzed on a
FACScan (Becton Dickinson). For multicolor flow cytometric
analysis, freshly isolated RA synovial cells were disaggregated es-
sentially as described before and resuspended in HBS, 2 mM
Ca
 
2
 
 
 
, 5% FBS, exposed to the following primary antibodies for
1 h at 4
 
 
 
C: IgG1-FITC, CD45-FITC, IgG1-biotin, or cadherin-
11-5H6-biotin followed by Cychrome-conjugated streptavidin
(BD Biosciences) for 1 h at 4
 
 
 
C and analyzed on a FACScan flow
cytometer.
 
In Vitro Cadherin-induced Multicellular Organization.
 
L cells
transfected with cadherin-11 or vector control were plated at 5 
 
 
 
10
 
4
 
 cells/ml (5 
 
 
 
 10
 
5
 
 cells/75 cm
 
2
 
 surface area). Cellular organi-
zation was examined after 4 d by phase-contrast microscopy. For
in vitro lining formation experiments, distinct areas of tissue cul-
ture flasks (Becton Dickinson) were coated with fibronectin
(GIBCO BRL) by applying fibronectin drops (0.1–10 
 
 
 
g/ml)
and incubation overnight at 4
 
 
 
C, followed by blocking of the en-
tire surface with 1% BSA in HBS with 1 mM CaCl
 
2
 
 overnight at
4
 
 
 
C. Cells were released essentially as described for adhesion as-
says and, after washing twice, were plated at 5 
 
 
 
 10
 
4
 
 cells/ml
in serum- and ECM-free media (X-VIVO 15; Cambrex Bio-
Science). Photographs were taken by phase microscopy after 2 d
at 37
 
 
 
C.
 
Online Supplemental Material.
 
The online supplemental mate-
rial includes descriptions of cloning of the synovial cadherin, gen-
eration of L cell transfectants, production and characterization of
cadherin-11–Fc fusion protein, and anti–cadherin-11 monoclonal
antibodies, including Fig. S1, and of other antibodies and cell
lines used in this work. Online supplemental material is available
at http://www.jem.org/cgi/content/full/jem.20041545/DC1.
 
Results and Discussion
 
Cloning of the Synoviocyte Cadherin.
 
To determine if
there is a cadherin that might function to mediate ho-
mophilic adhesion among synoviocytes, we performed
PCR amplification of human synovial fibroblast cDNA
using degenerate oligonucleotides based on the highly
conserved cytoplasmic domains in human cadherins, as de- 
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scribed in the online supplemental material (available at
http://www.jem.org/cgi/content/full/jem.20041545/DC1).
Six out of eight clones obtained matched the canonical
cadherin-11 sequence. Northern blot analysis confirmed
that the 4-kb cadherin-11 mRNA is present in total RNA
of cultured FLS derived from RA synovial tissue, but not
in RNA from epithelial cells (16E6.A5) or Jurkat T leuke-
mia cells (Fig. 1). PCR amplification of the entire coding
region of human cadherin-11 from FLS cDNA and nucle-
otide sequencing further confirmed the presence of bona-
fide cadherin-11 mRNA within cultured human FLS (see
online supplemental text).
 
Cadherin-11–Fc Supports Adhesion of Synoviocytes.
 
To
test the adhesive capacity of human cadherin-11, we pro-
duced cadherin-11–Fc fusion protein and monoclonal anti–
cadherin-11 antibodies (see online supplemental text and
Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20041545/DC1) and performed cell to substrate adhe-
sion assays. Both cultured FLS derived from RA synovium,
and cadherin-11–transfected L cells adhered to cadherin-
11–Fc in a concentration-dependent fashion (Fig. 2 A). In a
typical experiment, 
 
 
 
30–40% of FLS adhered to cadherin-
11–Fc. In contrast, only 5% of FLS adhered to control
E-cadherin–Fc (Fig. 2 A). Similarly, when the cadherin-11
gene was transfected into L cells (L/cad-11), these cells
bound efficiently to cadherin-11–Fc–coated plates, whereas
empty vector-transfected L cells (L/vector) bound only at
background levels (Fig. 2 B). The binding of cadherin-11
L cell transfectants to cadherin-11–Fc–coated wells was
blocked 80% by anti–cadherin-11 mAbs cadherin-11–2G4
and cadherin-11–5H6 (Fig. 2 C). The cadherin-11–3H10
mAb caused partial inhibition of adhesion (unpublished
data). In contrast, neither the isotype matched P3 mAb nor
the cell-binding mouse anti–MHC class I mAb (36–7-5)
blocked the adhesion of cadherin-11 L cell transfectants to
cadherin-11–Fc. Together, these findings are in agreement
with other reports of the ability of cadherin-11 to support
homophilic cell aggregation (13–15) and demonstrate for
the first time that cadherin-11 mediates homophilic adhe-
sion of cultured human RA-derived FLS.
 
Expression of Cadherin-11 in the Rheumatoid Synovium.
 
To determine if cadherin-11 protein was expressed in RA,
we performed immunohistochemistry of frozen human
synovial tissue sections from RA patients. First, we stained
RA synovium with anti-DAF (CD55), a marker expressed
by FLS in the synovial lining layer (Fig. 3 A). For compari-
son, we stained RA synovium with mAb against CD68,
which is expressed by synovial macrophages. As expected,
anti-CD68 labeled cells in both the lining and sublining re-
Figure 1. Northern analysis
of cadherin-11 expression. (A)
Northern blot of mRNA (5  g
per lane) from the 16E6.A5
breast epithelial cell line, human
RA-derived cultured FLS, and
Jurkat T cells was hybridized
with a 32P-labeled cadherin-11
(top) or control GAPDH probe
(bottom).
Figure 2. Cadherin-11–mediated adhesion of FLS and L cell transfectants.
(A) Adhesion of cultured FLS derived from RA synovium to cadherin-
11–Fc. Purified cadherin-11–Fc (open squares) or E-cadherin–Fc (closed
squares) were immobilized on microtiter plate wells coated with poly-
clonal goat anti–human IgG antibody and blocked with BSA. The adhe-
sion of RA-derived cultured FLS was determined in triplicate as described in
Materials and Methods. (B) Specific adhesion of L cells to cadherin-11–Fc is
conferred by cadherin-11 transfection. The assay was conducted as in A
using control L cells (L/vector) or cadherin-11–transfected L cells (L/cad-11)
and microtiter plates directly coated with the indicated concentrations of
Fc proteins (cadherin-11–Fc or control E-cadherin–Fc). (C) Inhibition of
adhesion of the L cell/cadherin-11 line to cadherin-11–Fc by anti–cadherin-
11 antibodies. The assay was performed as in B but antibodies were prein-
cubated with the cells for 10 min on ice. All the mAb were purified and
used at 10  g/ml and all mAb were mouse IgG1, except anti–mouse
MHC-I (mouse IgG2a). The results are expressed as the mean percentage
of cells that were adherent  1 SD (n   3). 
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gions (Fig. 3 B). The cadherin-11–3H10 mAb showed
prominent staining of the lining in RA synovium (Fig. 3
C). In addition, rare, strongly cadherin-11–reactive cells
were noted in the sublining region. A similar staining pat-
tern was noted in synovia from patients with osteoarthritis
(Fig. 3, D–F) and in normal synovium (Fig. 3, G–I), al-
though reactivity was of weaker intensity. These findings
contrast with results in skin and colonic tissues where no
cadherin-11–reactive cells were seen, whereas the expected
CD68 staining of tissue macrophages in all tissues and
E-cadherin in skin was observed (Fig. 3, J–N). We found
no evidence of E-cadherin expression in RA synovium (see
online supplemental text). In addition, we find that cad-
herin-11 is expressed in normal mouse synovial tissue, but
not in mouse skin (unpublished data).
Next, we tested whether RA-derived FLS expressed
cadherin-11 on their cell surfaces. In vitro–cultured, RA-
derived FLS stained with anti–cadherin-11–3H10 mAb by
flow cytometry (Fig. 3 O). Thus, all the data obtained, in-
cluding molecular cloning, Northern analysis, and flow cy-
tometry of cultured FLS, were consistent with cadherin-11
expression on FLS. To confirm that FLS cadherin-11 ex-
pression did not result from tissue culture artifact, we per-
formed multicolor flow cytometry on disaggregated fresh
ex vivo RA synovial tissue using anti–cadherin-11–5H6
mAb and anti-CD45 mAb (a lineage marker of bone mar-
row–derived cells). Cells expressing cadherin-11 predomi-
nantly lacked CD45, and cells expressing CD45 mainly
lacked cadherin-11, although a small population (
 
 
 
5%) of
CD45-expressing synovial cells was stained by the mAb
5H6 (Fig. 3 P). Together, the immunohistology and the
flow cytometry results indicated that within the inflamed
rheumatoid synovium cadherin-11 expression is found pre-
dominantly on the FLS lineage.
 
Cadherin-11 Mediates Tissue Sheet and Lining Formation In
Vitro.
 
Because classical cadherins mediate homophilic ad-
hesion that can result in cell sorting into aggregates and
tissue morphogenesis, we examined the potential of cad-
Figure 3. Cadherin-11 expression on FLS in the synovium. (A–N) Immunohistochemical analyses of frozen human tissue from RA synovium (A–C),
osteoarthritis (OA) synovium (D–F), normal synovium (G–I), skin (J–L), and colon (M and N) stained with anti-CD55 (A and D), anti-CD68 (B, E, H,
K, and M), anti–cadherin-11 (C, F, I, L, and N), IgG1 control (G), or anti–E-cadherin (J) are shown. Note the prominent cadherin-11 reactivity in the
synovial lining that was similar to CD55 reactivity and the absence of detectable cadherin-11 reactivity in skin and colonic sections. Note also the distinct
difference in reactivity pattern for the macrophage marker CD68. Magnification, 200. (O–R) Flow cytometry of FLS. Flow cytometry of passage three
RA-derived FLS revealed that, after in vitro culture, essentially all express cadherin-11 (O), whereas nonfibroblast lineages do not propagate. Flow cyto-
metric analyses of freshly disaggregated RA synovial cells, gated to exclude small particulate material by forward scatter, show separate subpopulations
stained by anti–cadherin-11–biotin/streptavidin-Cychrome and the bone marrow lineage marker CD45-FITC (P), compared with IgG1 controls (Q) or
to synovial cells stained with CD45-FITC and isotype control (R). 
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herin-11 to mediate the association of cells into tissue-like
sheets in vitro. L cells transfected with cadherin-11–con-
taining vectors (L/cad-11) or with empty pCEP4 vectors
(L/vector) were plated at equal numbers in tissue culture
flasks. After 4 d of culture, cadherin-11–expressing L cells
formed tight aggregates that grew as tissue-like sheets,
whereas empty vector-containing L cells grew as random
cells without specific cell–cell interactions (Fig. 4 A).
To examine the formation of cadherin-11–mediated in-
tercellular junctions in human FLS, we plated cultured FLS
at 50% confluence where cells are not crowded. After over-
night culture, the cells were well spread and contained actin
stress fibers (Fig. 4 B, left). Additionally, the FLS developed
numerous filopodial processes with the greatest number of
filopodia at sites of close cell–cell contact. Specifically, at
sites of intimate cell–cell contact with numerous interdigi-
tating filopodia, the anti–cadherin-11 antibody labeled a
ladder-like series of lines corresponding to intercellular
junctions (Fig. 4 B, middle, right, and schema). No cad-
herin-11 staining was seen at sites without cell–cell contact.
A perinuclear granular cadherin staining demonstrated that
FLS contained intracellular cadherin-11, consistent with
similar findings for E-cadherin (Fig. 4 B and reference 16).
In vivo, the synovial lining exists as a condensed cell
layer, one to three cells thick, overlying and imbedded in
the ECM of the synovial sublining that also contains small
blood vessels and scattered fibroblasts. The other side of the
lining layer faces the synovial space (Fig. 5 A). The basis for
the formation and organization of the synovial lining is un-
known. To study this process, we set up a culture system in
vitro to simulate synovial lining formation. To mimic the in
vivo setting of a tissue layer adjacent to the joint cavity, we
coated the ECM component fibronectin (representing syn-
ovial sublining ECM) onto discrete regions of a tissue cul-
ture flask. The surrounding plastic surface was blocked with
BSA (representing the joint cavity) and FLS were added in
serum- and ECM-free medium. After 2 d of culture, the
FLS formed a lining-like structure at the fibronectin–BSA
interface and formed visible interconnections with cells be-
low the interface, in a distribution resembling that in the
synovium (Fig. 5 B). To confirm that this phenomenon
could be accounted for by cadherin-11 expression, we
compared L cells expressing or lacking cadherin-11. When
L cells were plated in the same culture system, they adhered
randomly to the fibronectin-coated surface and did not
form a lining layer (Fig. 5 C). Strikingly, after culture for
2 d, L cells expressing cadherin-11 formed a lining-like struc-
ture at the fibronectin–BSA interface similar to that ob-
tained with FLS (Fig. 5 D). Although these studies do not
attempt to incorporate all of the cellular elements of the
synovial tissue, they support the hypothesis that cadherin-11
mediates intercellular adhesion that imparts morphologic
characteristics of the tissue in vivo. These include the for-
mation of tissue sheets and a lining-like layer at a matrix in-
terface, analogous to the interface between the loose con-
nective tissue matrix of the synovium and the joint space.
 
Implications for Synovial Lining Formation and RA.
 
Based
on our findings and the fact that cadherins are widely rec-
ognized to mediate tissue morphogenesis in development
and contribute to tissue architecture in the adult (2), we
propose that cadherin-11 may serve this function for the
synovium. Cadherin-11 may allow the homophilic adhe-
sion between FLS that is required for the process of cell re-
arrangement responsible for the organization of the syn-
ovial lining layer. Additional interactions including those
between FLS and macrophage-like synoviocytes, possibly
Figure 4. Cadherin-11 medi-
ates the formation of intercellular
junctions, tissue sheet-like and
lining-like cellular organization.
(A) Cadherin-11 mediates tissue–
sheet formation. Equal numbers
of L cells were plated on culture
dishes in conventional media.
After 4 d, L cells transfected with
vector alone were randomly or-
ganized without specific cell–cell
interactions. In contrast, cadherin-
11–transfected L cells formed ex-
tensive and intimate contacts
along their surfaces and con-
densed together to form a contin-
uous sheet of cells resembling a
tissue-like structure. (B) Forma-
tion of cadherin-11 mediated in-
tercellular junctions. FLS were
plated at intermediate density
and, after overnight culture, sub-
jected to immunofluorescence
using phalloidin to label F-actin
(green, left) and anti–cadherin-11
3H10 (red, middle). A merged image is shown in at right. F-actin staining demonstrated numerous filopodia that interdigitated with those from neigh-
boring cells. At the cell periphery, the anti–cadherin-11-3H10 mAb–labeled intercellular junctions resulted in a row of short parallel lines (middle, right,
and schematic representation). Bars, 10  m. 
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through VCAM-1 and integrin 
 
 
 
4
 
 
 
1 (6, 9), are likely to
contribute to the overall structure of the synovium in vivo.
Our data indicate that synovial fibroblasts, but not all fi-
broblasts, express cadherin-11 in vivo. Cadherin-11 is also
expressed on another important cell type in close proximity
to the diarthrodial joint, the osteoblast (15). Indeed, mice
lacking functional cadherin-11 demonstrate bone abnor-
malities (17). Although the complete tissue distribution of
cadherin-11 in adult humans is unknown, mRNA expres-
sion has been noted in placenta, brain, lung, and heart (14,
18). Thus, cadherin-11 is selectively but not uniquely ex-
pressed on FLS.
Unlike other cadherins, cadherin-11 is expressed pre-
dominantly on mesenchymal tissues (13, 19, 20). During
development, the expression of cadherin-11 in the placenta
and in embryonic tissues, such as developing limb buds and
branchial arches, indicates a role in outgrowing or extend-
ing tissue (13, 19–22). These features suggest that cadherin-
11 plays an important role in limb and joint development
(4, 13, 20). Our findings raise the possibility that cadherin-
11 also participates in synovial development. Future studies
in cadherin-11–deficient mice should provide insight into
this unexplored process.
It is important to consider that fundamental differences
may exist between the functions of epithelial cadherins,
such as E-cadherin, and mesenchymally expressed cad-
herins, such as cadherin-11. Unlike E-cadherin, cadherin-
11 may be associated with a mesenchymal invasive tissue
phenotype. Interestingly, although epithelial tissues nor-
mally do not express cadherin-11, expression has been
noted on breast and prostate carcinomas that normally ex-
press E-cadherin. In these tumor cells, the anomalous ex-
pression of cadherin-11 at high levels has been correlated
with invasive tumor behavior (2, 4, 5). Furthermore, cad-
herin-11 transfection is reported to increase the invasive
and migratory properties of an E-cadherin expressing breast
carcinoma cell line in vitro (23). Thus, it will be important
to determine if cadherin-11 participates in the locally inva-
sive behavior of the rheumatoid synovium.
In addition to their role in regulating cell to cell adhe-
sion, cadherins also modulate other cell functions via intra-
cellular signaling pathways (2). Thus, cadherin-11 likely
plays a role in regulating the behavior of RA FLS that are
capable of foci formation, anchorage-independent growth
in soft agar, and invasive tumor-like behavior in SCID
mice (24, 25). It is also intriguing that cell contact between
fibroblasts mediated by cadherin-11 induces up-regulation
of endothelial growth factor VEGF-D gene expression
(26), and that in embryonic lung, only cadherin-11–express-
ing cells appear to produce VEGF-D (27). Therefore, it is
possible that synovial cadherin-11 expression also contrib-
utes to the increased angiogenesis in RA (28).
Our identification of a synovial cadherin and its expres-
sion in normal and RA FLS offer a previously unrecognized
opportunity to understand the structural basis for this tissue
and the biology of the synovium. FLS of the synovial lining
are of great interest in understanding both the normal phys-
iology of the joint and how it is damaged in synovitis. In the
normal synovium, FLS participate in the active process of
synovial homeostasis via production of matrix components,
matrix remodeling enzymes, and enzyme inhibitors. In
pathological states such as RA, it remains unclear whether
synovial lining hyperplasia results from underlying inflam-
mation in the synovium or from primary abnormalities of
FLS. Nevertheless, FLS are key producers of matrix-damag-
ing enzymes (MMPs), cytokines (IL-6), growth factors (FGF),
and angiogenic factors (VEGF) during inflammatory arthri-
tis (29), and fibroblast-like cells are the major population in
the invasive pannus that ultimately leads to joint destruc-
tion. Many of the processes that are key to rheumatoid syn-
ovitis, such as cellular condensation, tissue extension, and
invasive behavior, have been linked to cadherin function.
Therefore, the synovial cadherin may have a determining
role in the mesenchymal tissue response to chronic inflam-
mation. A new focus on the role of cadherin-11 in FLS bio-
logy will provide new insights into the aggressive behavior
of the synovial tissue in conditions such as RA.
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interface similar to that of FLS in B (200 , phase-contrast). 
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